NDC 71335-1767 – Butalbital, Acetaminophen, Caffeine

Butalbital 50 mg/1; Acetaminophen 325 mg/1; Caffeine 40 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIII 1 recall

Product NDC71335-1767

Product details

Brand name
Butalbital, Acetaminophen, Caffeine
Generic name
Butalbital, Acetaminophen, and Caffeine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA209587
Marketed since
March 5, 2019
Listing expires
December 31, 2026
Pharmacologic class
Barbiturate; Central Nervous System Stimulant; Methylxanthine

Active ingredients

Uses, dosage, side effects and warnings for Butalbital, Acetaminophen, Caffeine →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1767-084 TABLET in 1 BOTTLE (71335-1767-0)Feb 18, 2021
71335-1767-120 TABLET in 1 BOTTLE (71335-1767-1)Feb 18, 2021
71335-1767-230 TABLET in 1 BOTTLE (71335-1767-2)Feb 18, 2021
71335-1767-360 TABLET in 1 BOTTLE (71335-1767-3)Feb 18, 2021
71335-1767-490 TABLET in 1 BOTTLE (71335-1767-4)Feb 18, 2021
71335-1767-550 TABLET in 1 BOTTLE (71335-1767-5)Feb 18, 2021
71335-1767-66 TABLET in 1 BOTTLE (71335-1767-6)Feb 18, 2021
71335-1767-7120 TABLET in 1 BOTTLE (71335-1767-7)Feb 18, 2021
71335-1767-840 TABLET in 1 BOTTLE (71335-1767-8)Feb 18, 2021
71335-1767-912 TABLET in 1 BOTTLE (71335-1767-9)Feb 18, 2021

Recalls mentioning this NDC

Other Butalbital, Acetaminophen, Caffeine products